Oct 2026· Translational Research: The Journal of Laboratory and Clinical Medicine· Vol 298, pp. 166-181· 0 citations· 156 references
Medicine
TL;DR
Future precision strategies integrating biomarkers, multi-omics profiling, and imaging-based risk stratification with stage-specific therapeutic interventions are discussed and future precision strategies integrating biomarkers, multi-omics profiling, and imaging-based risk stratification with stage-specific therapeutic interventions are discussed.
Abstract
Abdominal aortic aneurysm (AAA) is a chronic vascular disorder characterized by progressive aortic wall dilation, extracellular matrix degradation, and an increased risk of catastrophic rupture. Currently, no effective pharmacological therapy is available to prevent or slow AAA progression. Neutrophil extracellular traps (NETs) have emerged as a critical pathological platform linking dysregulated innate immunity to vascular structural deterioration. In the AAA microenvironment, local inflammation, oxidative stress, metabolic disturbances, altered mechanical forces, and platelet activation collectively contribute to the induction of NETosis. Persistent NET formation promotes immunoinflammatory remodeling of the aortic wall by activating inflammatory sensing pathways, including TLR9, cGAS-STING, and NLRP3, modulating macrophage responses, inducing vascular smooth muscle cell ferroptosis and phenotypic switching, and exacerbating proteolytic degradation, oxidative injury, and immunothrombotic responses. During disease progression, NETs may transition from early drivers of inflammatory amplification to sustained regulators of vascular remodeling, while in advanced AAA they may synergize with intraluminal thrombus formation and structural destabilization to accelerate disease progression. Circulating NET-associated biomarkers represent promising candidates for complementing conventional imaging-based risk assessment; however, their specificity and predictive value require further validation. Therapeutic strategies targeting PAD4-mediated NET formation, the oxidative metabolic environment, NET-associated effector molecules, DNase I-mediated NET degradation, and nucleic acid sensing pathways have demonstrated potential in preclinical studies. This review systematically summarizes the emerging roles of NETs in AAA pathogenesis and discusses future precision strategies integrating biomarkers, multi-omics profiling, and imaging-based risk stratification with stage-specific therapeutic interventions.
A framework highlights NETs as both mechanistic drivers and promising therapeutic targets in atherosclerotic cardiovascular disease and describes the molecular mechanisms of NET formation and the cooperative actions of NET components as an integrated thrombo‐inflammatory platform.
Ji Zhang, Fangjiaqi Wei, Meng-Di Qu et al.· MedComm· 0 citations
The present review systematically delineated the interaction networks between NETs and macrophages, monocytes, endothelial cells, fibroblasts and platelets, untangling NETs as a central hub that integrates the pathological triad of inflammation, thrombosis and fibrosis in cardiovascular diseases.
Zhao Wang, Ming-Der Y. Chang, Wen-Yu Shang et al.· International Journal of Mol...· 0 citations
Calcific aortic valve disease (CAVD) is a prevalent degenerative valvular disorder in the aging population, for which no pharmacological therapy has proven effective in halting or reversing disease progression. Over the past decade, CAVD has been increasingly recognized not as a passive degenerative process of calcium...
Xi Zhang, Yi Si, Li-Mao Liao et al.· Frontiers in Immunology· 0 citations
A regional view of intracranial aneurysm progression is supported in which mechanical, inflammatory, and structural processes interact within a heterogeneous vessel wall.
Jun Zhu, Liu-Xun Hu, Mei Wu et al.· Frontiers in Molecular Biosc...· 0 citations
This chapter outlines the cellular and molecular mechanisms governing efferocytosis and SPM signalling and how these processes become disrupted during plaque progression, contributing to persistent inflammation and defective clearance of dying cells in atherosclerotic plaques.
Manikandan Subramanian· Current Topics in Microbiolo...· 0 citations
Chronic inflammation contributes to the pathogenesis of intracranial aneurysms (IAs). However, existing studies have generally focused on individual stages of IA pathogenesis. This narrative review synthesizes evidence across all stages of the natural history of IA: formation, progression, and rupture. During formation...
G. Soetanto, A. Permana, Nurullah Tasrif et al.· The Neuroscientist· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.